The Center for Technology Licensing (CTL) is Cornell University's technology transfer office.
We manage technology for Cornell's Ithaca campus, Weill Cornell Medical Colleges, Cornell Tech, and Cornell AgriTech in Geneva.
A volunteer role at CTL for individuals with expertise in commercialization, venture formation, intellectual property protection, marketing and other business areas who are interested in helping Cornell make advancements in technology commercialization. Individuals in these roles will advise CTL on technology commercialization and help connect CTL with industry partners.
Robert S. Langer is heralded as one of the most prolific inventors in the history of medicine, as well as the father of controlled drug release and tissue engineering. As a young researcher confronted with the problem of accurate drug delivery, he reversed the usual process of working with existing materials, and custom-designed new polymers (plastics) to release medication at a desired rate. His discoveries have saved countless lives and helped launch a $100-billion-a-year industry that includes products ranging from the nicotine patch to coated cardiovascular stents. His inventions include dime-size implantable wafers for the treatment of cancer, drug release systems operated by remote control, and an implantable “pharmacy on a chip” that releases precise quantities of drugs on a programmable schedule.
Langer pioneered the new field of tissue engineering by growing transplantable tissue in vitro on biodegradable plastic scaffolding. Skin grown using Langer’s principles has been approved by the FDA, cartilage is in clinical trials, and his engineered spinal tissue has been successfully transplanted in laboratory animals. Every year, thousands of Americans die awaiting transplants of organs like the liver, heart and lung, but Robert Langer is creating a future where spare organs can be grown in the laboratory.
Dr. Langer has received the highest professional honors for his work, including the Charles Stark Draper Prize, the National Medal of Science, the National Medal of Technology and Innovation, the Priestley Medal, the Wolf Prize, the £1 million Queen Elizabeth Prize, and the $3 million Breakthrough Prize in Life Sciences. In addition to his endowed chair at MIT, he is a faculty member of the Harvard-MIT Division of Health Sciences and Technology and the David H. Koch Institute for Integrative Cancer Research. His research laboratory at MIT is the largest academic biomedical engineering lab in the world, maintaining about $10 million in annual grants and over 100 researchers.
President and Founder – The CBORD Group Inc.
Trustee Emeritus – Cornell University
John E. Alexander (Cornell AB ’74, MBA ’76) is the founder of The CBORD Group Inc., a systems integration firm based in Ithaca, NY. He earned an undergraduate degree in physics and an MBA in finance while at Cornell. Immediately after graduation, he was vice president in the Money Market Division of Bankers Trust Company (now Deutsche Bank.) in their Eurodollar trading operation.
As President and CEO of CBORD, Mr. Alexander led CBORD through 29 years of growth. The CBORD Group, founded in 1975, is the world’s leading provider of campus and cashless card systems, food and nutrition service management software, nationwide student discount and off-campus commerce programs, housing and judicial process management software, and integrated security solutions. Mr. Alexander stepped down as the CEO in 2004 and from the board in 2008 after the acquisition by Roper Industries.
Mr. Alexander was elected to Cornell’s Board of Trustees by the alumni body to a four-year term beginning July 1, 2000, and was reelected in 2004. He has served on numerous committees, and chaired the Audit Committee for 3 years, taking the university through the Sarbanes Oxley process. He currently serves at a Trustee Emeritus and Presidential Councilor. He serves on the advisory councils of the Entrepreneurship@Cornell (E@C) Program, the Johnson School, and is the alumni advisor to the Johnson Board Fellows program and BR Consulting. He also serves on the community advisory board of the Johnson Art Museum. He was the 1987-88 Dorothy M. Proud Lecturer at Cornell’s Division of Nutritional Sciences. He currently chairs the executive committee of the Sphinx Head Society, Cornell’s first undergraduate honor society. Ernst and Young selected Mr. Alexander as the Upstate New York Technology Entrepreneur of the in 2002. Cornell selected Alexander as its 2012 Entrepreneur of the Year.
John and Elaine Alexander were honored in 2014 as recipients of Cornell’s prestigious Frank H. T. Rhodes Exemplary Alumni Service Award for their service to Cornell.
Founder, Chairman of the Board of Directors, Achronix Semiconductor Corporation
From 2004 to 2011, Mr. Holt served as Chairman & CEO of Achronix. In this role, Mr. Holt raised over $120M at Achronix and led the company from its first business plan to the launch of the world’s highest performance FPGA product in 2008. From 2008 to 2011 Mr. Holt scaled the team and drove a historic partnership with Intel Corporation to build the world’s most advanced FPGAs in Intel’s 22nm process. In 2011, Mr. Holt brought Robert Blake onto the Achronix team as the CEO. In his current role as Chairman of the Board, Mr. Holt leads business development activities for the company and drives a variety of global strategic initiatives. Before co-founding Achronix Semiconductor, Mr. Holt founded and led S3, a management technology and venture consulting firm in Washington DC. Under Mr. Holt’s leadership, the firm built a multi-million dollar business with Fortune 100 and startup clients. Prior to founding S3, Mr. Holt worked as a management consultant at PricewaterhouseCoopers and Booz Allen Hamilton.
Mr. Holt started his career at NASA’s Goddard Space Flight Center in 1989 and worked as a design engineer until 1997. Mr. Holt is educated as an Electrical Engineer and Physicist with a Bachelor of Science in Electrical Engineering from Princeton University and a Masters of Science in Electrical Engineering from Johns Hopkins University. He is a frequent lecturer at Cornell University on a variety of topics including entrepreneurship, management, and technology commercialization.
Acting Chief Medical Officer and Director of Medical Content and Business Development, Acupera
Dr. Ryan Luginbuhl is the Acting Chief Medical Officer and Director of Medical Content and Business Development for Acupera, a leading digital health company. He has extensive experience as a practicing physician, digital health executive, entrepreneur, and advisor. He has managed a clinical workflow software team to develop enterprise, cloud-based solutions for large medical organizations (e.g., ACOs) to conduct population health and chronic care management. He has extensive experience in the creation of transitional care management and chronic care management software.
He graduated with honors and Phi Beta Kappa from Cornell University with a Bachelor of Arts in Biology and a concentration in Neurobiology. After college he received a prestigious DAAD Deutschlandjahr Scholarship to study visual attention in primates at the University of Goettingen in Germany. He received his Medical Degree from Washington University School of Medicine. While training in General Surgery at Brigham and Women’s Hospital in Boston, Dr. Luginbuhl developed a passion for digital health. He is President of Cornell NorCal, a 501(c)(3) nonprofit organization, where he focuses on creating engaging tech and entrepreneurial-related events in the Bay Area.
Former Partner at Ropes & Gray LLP
Larry Rogers is a patent attorney with more than 40 years of litigation, licensing, prosecution, and counseling experience. Recently retired, Larry was a partner in Ropes & Gray’s Intellectual Property Litigation group, having joined the firm in 2005 when it merged with Fish & Neave, where Larry was also a partner. As lead trial counsel, Larry tried cases to both bench and jury in district court and before the International Trade Commission, and argued in the Federal Circuit Court of Appeals. His cases involved a wide range of technologies, including computer processors and systems, software, linear and digital integrated circuits, semiconductor processing, the Internet, cloud computing, cryptography, cellular and wireline telephony, Wi-Fi, security systems, video systems, medical devices, digital imaging, graphics, animation, financial services systems, and trading platforms. Larry also regularly advised clients concerning intellectual property licensing, asset management, due diligence, and post-grant (IPR and CBM) Patent Trial and Appeal Board proceedings. He was recognized for his expertise and results by Best Lawyers in America, New York Super Lawyers, and Managing IP as an “IP Star.”
Larry received a J.D. degree from New York University School of Law in 1975, and a BS with Distinction from Cornell University (E.E.) in 1972.